Boston Scientific Corporation BSX
NYSE
Recommendation
Dividend Power Score
Day's Range
$41.92$43.23
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 583.00M | 906.00M | 1.34B | 672.00M | 755.00M |
| Total Depreciation and Amortization | 361.00M | 355.00M | 351.00M | 365.00M | 342.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 202.00M | 139.00M | -429.00M | 172.00M | 202.00M |
| Change in Net Operating Assets | -98.00M | 74.00M | -915.00M | 155.00M | 44.00M |
| Cash from Operations | 1.05B | 1.47B | 348.00M | 1.36B | 1.34B |
| Capital Expenditure | -180.00M | -195.00M | -177.00M | -351.00M | -181.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -212.00M | -195.00M | -523.00M | -89.00M | -256.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -45.00M | -1.57B | 109.00M | -72.00M | -65.00M |
| Cash from Investing | -437.00M | -1.96B | -591.00M | -512.00M | -502.00M |
| Total Debt Issued | -672.00M | 1.68B | -- | 0.00 | -1.00M |
| Total Debt Repaid | 0.00 | -13.00M | -259.00M | -209.00M | -215.00M |
| Issuance of Common Stock | 95.00M | 5.00M | 81.00M | 20.00M | 115.00M |
| Repurchase of Common Stock | 0.00 | -2.00B | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 8.00M | -77.00M | -82.00M | 5.00M | -3.00M |
| Cash from Financing | -569.00M | -410.00M | -260.00M | -184.00M | -104.00M |
| Foreign Exchange rate Adjustments | 2.00M | 1.00M | -- | 3.00M | -2.00M |
| Miscellaneous Cash Flow Adjustments | -- | 1.00M | -1.00M | -- | -- |
| Net Change in Cash | 44.00M | -890.00M | -504.00M | 671.00M | 735.00M |